US Patent

US12290651 — Devices and methods for the treatment of body surface disorders

Formulation · Assigned to Verrica Pharmaceuticals Inc · Expires 2041-02-19 · 15y remaining

Vulnerability score 55/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects devices and methods for treating body surface conditions by facilitating topical administration of a pharmaceutical composition, such as Ycanth.

USPTO Abstract

Applicator devices ( 1 ), kits, systems, and methods of using such devices for treating one or more body surface conditions (e.g., warts, Molluscum contagiosum, conjunctivitis, otitis) are provided. The applicator device facilitates topical administration of a controllable amount of a pharmaceutical composition to a desired area of an affected body surface (e.g., skin, eye, ear, nose, mouth, anus, vagina). The applicator device includes an ampule ( 40 ) containing the pharmaceutical composition, the ampule being positioned within a tube ( 50 ). Squeezing the tube breaks the ampule, releasing the pharmaceutical composition. The applicator device includes a filter ( 30 ) that permits passage of fluid and inhibits passage of broken ampule shards. The applicator device includes a dispensing tip ( 20 ) through which the pharmaceutical composition passes.

Drugs covered by this patent

Patent Metadata

Patent number
US12290651
Jurisdiction
US
Classification
Formulation
Expires
2041-02-19
Drug substance claim
No
Drug product claim
Yes
Assignee
Verrica Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.